journal article·2016-01

Poly(ethylene glycol)-b-poly(lysine) copolymer bearing nitroaromatics for hypoxia-sensitive drug delivery

Thavasyappan Thambi, Soyoung Son, Doo Sung Lee, Jae Hyung Park

Acta Biomaterialia· Volume 29
Publisher page

Abstract

Hypoxia occurs in a variety of pathological conditions including stroke, rheumatoid arthritis, atherosclerosis, and tumors. In this study, an amphiphilic block copolymer, composed of poly(ethylene glycol) as the hydrophilic block and poly(ε-(4-nitro)benzyloxycarbonyl-L-lysine) as the hydrophobic block, was prepared for hypoxia-sensitive drug delivery. Owing to its amphiphilic nature, the block copolymer formed micelles and encapsulated doxorubicin (DOX) in an aqueous condition. The DOX-loaded micelles exhibited rapid intracellular release of DOX under the hypoxic condition, implying high potential as a drug carrier for cancer therapy. Statement of significance Hypoxia occurs in a variety of pathological conditions including stroke, rheumatoid arthritis, atherosclerosis, and tumors. In this study, we developed a novel type of hypoxia-sensitive polymeric micelles (HS-PMs) that can specifically release the drug under the hypoxic conditions. HS-PMs were prepared using poly(ethylene glycol) as the hydrophilic block and poly(ε-(4-nitro)benzyloxycarbonyl-L-lysine) as the hydrophobic block. Owing to its amphiphilic nature, the block copolymer formed micelles and encapsulated doxorubicin (DOX) in an aqueous condition. The DOX-loaded micelles exhibited rapid intracellular release of DOX under the hypoxic condition. Overall, it is evident that the HS-PMs prepared in this study have the potential to effectively deliver hydrophobic drugs into the hypoxic cells involved in various intractable diseases.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Cancer, Hypoxia, and Metabolism

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. Hypoxia –– a key regulatory factor in tumour growth10.1038/nrc704 ↗
2. The impact of O2 availability on human cancer10.1038/nrc2540 ↗
3. Interfering with pH regulation in tumours as a therapeutic strategy10.1038/nrd3554 ↗
4. Applications of nitroimidazole in vivo hypoxia imaging in ischemic stroke10.1161/STROKEAHA.107.485938 ↗
5. PH-responsive polymeric micelle based on PEG-poly(β-amino ester)/(amido amine) as intelligent vehicle for magnetic resonance imaging in detection of cerebral ischemic area10.1016/j.jconrel.2010.09.012 ↗
6. Squalenoyl adenosine nanoparticles provide neuroprotection after stroke and spinal cord injury10.1038/nnano.2014.274 ↗
7. Chemical radiosensitizers for use in radiotherapy10.1016/j.clon.2007.03.010 ↗
8. Targeting hypoxia in cancer therapy10.1038/nrc3064 ↗
9. A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell10.1021/ol102975t ↗
10. Hypoxia as a target for tissue specific gene therapy10.1016/j.jconrel.2013.05.021 ↗
11. Hypoxia-activated prodrugs in cancer therapy: progress to the clinic10.2217/fon.10.1 ↗
12. Hypoxia-sensitive fluorescent probes for in vivo real-time fluorescence imaging of acute ischemia10.1021/ja105937q ↗
13. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
14. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery10.1038/nrd4333 ↗
15. Biodegradable and crosslinkable PPF-PLGA-PEG self-assembled nanoparticles dual-decorated with folic acid ligands and Rhodamine B fluorescent probes for targeted cancer imaging10.1039/C5RA04096E ↗
16. ATP-triggered anticancer drug delivery10.1038/ncomms4364 ↗
17. Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound10.1016/j.jconrel.2012.04.041 ↗
18. A hyaluronic acid-methotrexate conjugate for targeted therapy of rheumatoid arthritis10.1039/c4cc02595d ↗
19. Bioreducible carboxymethyl dextran nanoparticles for tumor-targeted drug delivery10.1002/adhm.201300691 ↗
20. Dual stimuli-responsive multi-drug delivery system for the individually controlled release of anti-cancer drugs10.1039/C4CC08831J ↗
21. In vivo multimodality imaging and cancer therapy by near-infrared light-triggered trans-platinum pro-drug-conjugated upconverison nanoparticles10.1021/ja410028q ↗
22. Photosensitive Pt(IV)–azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo10.1016/j.jconrel.2013.10.020 ↗
23. Tumor redox heterogeneity-responsive prodrug nanocapsules for cancer chemotherapy10.1002/adma.201300929 ↗
24. Enhancing neurogenesis and angiogenesis with target delivery of stromal cell derived factor-1α using a dual ionic pH-sensitive copolymer10.1016/j.biomaterials.2015.05.025 ↗
25. Recent advances in shell-sheddable nanoparticles for cancer therapy10.1166/jbn.2014.1977 ↗
26. Exploiting tumour hypoxia in cancer treatment10.1038/nrc1367 ↗
27. Pushing tumor cells towards a malignant phenotype: stimuli from the microenvironment, intercellular communications and alternative roads10.1002/ijc.28572 ↗
28. Tumor microenvironment and nanotherapeutics
29. The role of hypoxia-induced factors in tumor progression10.1634/theoncologist.9-90005-10 ↗
30. Hypoxia-specific ultrasensitive detection of tumours and cancer cells in vivo10.1038/ncomms6834 ↗
31. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery10.1016/j.biomaterials.2013.11.022 ↗
32. The preparation of N-carboxyanhydrides of α-amino acids using bis(trichloromethyl)carbonate10.1016/S0040-4039(00)82209-1 ↗
33. Synthesis and physicochemical characterization of amphiphilic block copolymers bearing acid-sensitive orthoester linkage as the drug carrier10.1016/j.polymer.2011.08.024 ↗
34. Novel polyion complex micelles entrapping enzyme molecules in the core: preparation of narrowly-distributed micelles from lysozyme and poly(ethylene glycol)−poly(aspartic acid) block copolymer in aqueous medium10.1021/ma971277v ↗
35. Ketal cross-linked poly(ethylene glycol)-poly(amino acid)s copolymer micelles for efficient intracellular delivery of doxorubicin10.1021/bm101517x ↗
36. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery10.1021/bm5017755 ↗
37. Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study10.1021/ma00005a010 ↗
38. Synthesis and physicochemical characterization of reduction-sensitive block copolymer for intracellular delivery of doxorubicin10.1007/s13233-013-1014-9 ↗
39. Carboxymethyl dextran-cyclodextrin conjugate as the carrier of doxorubicin10.1166/jnn.2013.8091 ↗
40. Redox-sensitive polymeric nanoparticles for drug delivery10.1039/c2cc31463k ↗
41. Bioreducible block copolymers based on poly(ethylene glycol) and poly(γ-benzyl l-glutamate) for intracellular delivery of camptothecin10.1021/bc2000963 ↗
42. Bioreducible polymersomes for intracellular dual-drug delivery10.1039/c2jm34546c ↗
43. Submersible microbial fuel cell sensor for monitoring microbial activity and BOD in groundwater: focusing on impact of anodic biofilm on sensor applicability10.1002/bit.23204 ↗
44. Drug delivery systems: entering the mainstream10.1126/science.1095833 ↗
45. Physicochemical characteristics of self-assembled nanoparticles based on glycol chitosan bearing 5β-cholanic acid10.1021/la0350608 ↗
46. Imaging hypoxia to improve radiotherapy outcome10.1038/nrclinonc.2012.171 ↗
47. 2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia10.1021/bc2004704 ↗
48. Highly discriminating photorelease of anticancer drugs based on hypoxia activatable phototrigger conjugated chitosan nanoparticles10.1002/adma.201204455 ↗
49. Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action10.1093/jac/31.1.9 ↗
50. Nitroreductase-triggered activation of a novel caged fluorescent probe obtained from methylene blue10.1039/C5CC03824C ↗
51. Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitroreductase enzyme10.1021/jm00047a002 ↗
52. A highly sensitive long-wavelength fluorescence probe for nitroreductase and hypoxia: selective detection and quantification10.1039/c3cc45367g ↗